---
schema_version: "secwatch.filing_event.v1"
accession: "0001641489-25-000030"
form_type: "8-K"
ticker: "VTVT"
cik: "0001641489"
company_name: "vTv Therapeutics Inc."
filed_at: "2025-05-16T23:59:59+00:00"
generated_at: "2026-05-21T03:21:57.143988+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# vTv Therapeutics posts May 2025 investor presentation on website

## Summary
- Presentation posted on May 16, 2025 for use in investor and analyst meetings.
- Slide deck highlights the company's focus on type 1 diabetes.
- No new financial or clinical data were disclosed in the presentation.

## SEC filing metadata
- accession: 0001641489-25-000030
- form_type: 8-K
- ticker: VTVT
- cik: 0001641489
- company_name: vTv Therapeutics Inc.
- filed_at: 2025-05-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641489/000164148925000030/0001641489-25-000030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641489/000164148925000030/vtvt-20250516.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641489-25-000030
- JSON: https://secwatch.observer/filing/0001641489-25-000030.json
- Plain text: https://secwatch.observer/filing/0001641489-25-000030.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.